On Invalid Date, Aurora Cannabis (NASDAQ: ACB) reported Q4 2023 earnings per share (EPS) of -$1.50, up 58.48% year over year. Total Aurora Cannabis earnings for the quarter were -$19.22 million. In the same quarter last year, Aurora Cannabis's earnings per share (EPS) was -$0.95.
As of Q1 2024, Aurora Cannabis's earnings has grown year over year. Aurora Cannabis's earnings in the past year totalled -$106.90 million.
What was ACB's revenue last quarter?
On Invalid Date, Aurora Cannabis (NASDAQ: ACB) reported Q4 2023 revenue of $48.44 million up 8.62% year over year. In the same quarter last year, Aurora Cannabis's revenue was $44.59 million.
What was ACB's revenue growth in the past year?
As of Q1 2024, Aurora Cannabis's revenue has grown 30.77% year over year. This is 21 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 9.78%. Aurora Cannabis's revenue in the past year totalled $199.23 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.